Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 227

1.

Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.

Sigel CS, Moreira AL, Travis WD, Zakowski MF, Thornton RH, Riely GJ, Rekhtman N.

J Thorac Oncol. 2011 Nov;6(11):1849-56. doi: 10.1097/JTO.0b013e318227142d.

PMID:
21841504
[PubMed - indexed for MEDLINE]
2.

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.

Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM.

J Thorac Oncol. 2010 Apr;5(4):442-7. doi: 10.1097/JTO.0b013e3181d40fac.

PMID:
20195168
[PubMed - indexed for MEDLINE]
3.

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.

J Thorac Oncol. 2010 Apr;5(4):436-41. doi: 10.1097/JTO.0b013e3181c6ed9b.

PMID:
20068475
[PubMed - indexed for MEDLINE]
4.

Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.

Noh S, Shim H.

Lung Cancer. 2012 Apr;76(1):51-5. doi: 10.1016/j.lungcan.2011.09.008. Epub 2011 Oct 5.

PMID:
21978426
[PubMed - indexed for MEDLINE]
5.

Cyto-histologic agreement in pathologic subtyping of non small cell lung carcinoma: review of 602 fine needle aspirates with follow-up surgical specimens over a nine year period and analysis of factors underlying failure to subtype.

da Cunha Santos G, Lai SW, Saieg MA, Geddie WR, Pintilie M, Tsao MS, Boerner SL, Hwang D.

Lung Cancer. 2012 Sep;77(3):501-6. doi: 10.1016/j.lungcan.2012.05.091. Epub 2012 May 31.

PMID:
22656670
[PubMed - indexed for MEDLINE]
6.

Are EUS-FNA and EBUS-TBNA specimens reliable for subtyping non-small cell lung cancer?

Tournoy KG, Carprieaux M, Deschepper E, van Meerbeeck JP, Praet M.

Lung Cancer. 2012 Apr;76(1):46-50. doi: 10.1016/j.lungcan.2011.09.004. Epub 2011 Sep 25.

PMID:
21945658
[PubMed - indexed for MEDLINE]
7.

Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.

Nizzoli R, Tiseo M, Gelsomino F, Bartolotti M, Majori M, Ferrari L, De Filippo M, Rindi G, Silini EM, Guazzi A, Ardizzoni A.

J Thorac Oncol. 2011 Mar;6(3):489-93. doi: 10.1097/JTO.0b013e31820b86cb.

PMID:
21258246
[PubMed - indexed for MEDLINE]
8.

Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.

Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.

Clin Cancer Res. 2010 Jan 15;16(2):610-9. doi: 10.1158/1078-0432.CCR-09-2638. Epub 2010 Jan 12.

PMID:
20068099
[PubMed - indexed for MEDLINE]
Free Article
9.

[Non-small cell lung cancer. Subtyping and predictive molecular marker investigations in cytology].

Savic S, Bihl MP, Bubendorf L.

Pathologe. 2012 Jul;33(4):301-7. doi: 10.1007/s00292-012-1577-9. Review. German.

PMID:
22711372
[PubMed - indexed for MEDLINE]
10.

Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing.

Rekhtman N, Brandt SM, Sigel CS, Friedlander MA, Riely GJ, Travis WD, Zakowski MF, Moreira AL.

J Thorac Oncol. 2011 Mar;6(3):451-8. doi: 10.1097/JTO.0b013e31820517a3.

PMID:
21266922
[PubMed - indexed for MEDLINE]
11.

Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.

Ocque R, Tochigi N, Ohori NP, Dacic S.

Am J Clin Pathol. 2011 Jul;136(1):81-7. doi: 10.1309/AJCPFKOLGL6PMOF3.

PMID:
21685035
[PubMed - indexed for MEDLINE]
Free Article
12.

Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.

Warth A, Muley T, Herpel E, Meister M, Herth FJ, Schirmacher P, Weichert W, Hoffmann H, Schnabel PA.

Histopathology. 2012 Dec;61(6):1017-25. doi: 10.1111/j.1365-2559.2012.04308.x. Epub 2012 Aug 8.

PMID:
22882703
[PubMed - indexed for MEDLINE]
13.

Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings.

Aikawa E, Kawahara A, Hattori S, Yamaguchi T, Abe H, Taira T, Azuma K, Kage M.

Cancer Cytopathol. 2011 Oct 25;119(5):335-45. doi: 10.1002/cncy.20162. Epub 2011 Jun 29.

PMID:
21717589
[PubMed - indexed for MEDLINE]
14.

Subtyping of nonsmall cell lung cancer on cytology specimens: reproducibility of cytopathologic diagnoses on sparse material.

Omland SH, Henrik H, Olsen EK, Birthe T, Guldhammer SB.

Diagn Cytopathol. 2014 Feb;42(2):105-10. doi: 10.1002/dc.22995. Epub 2013 May 17.

PMID:
23687077
[PubMed - indexed for MEDLINE]
15.

Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.

Esterbrook G, Anathhanam S, Plant PK.

Lung Cancer. 2013 Apr;80(1):30-4. doi: 10.1016/j.lungcan.2012.12.017. Epub 2013 Jan 10.

PMID:
23312886
[PubMed - indexed for MEDLINE]
16.

TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material.

Kalhor N, Zander DS, Liu J.

Mod Pathol. 2006 Aug;19(8):1117-23. Epub 2006 May 5.

PMID:
16680154
[PubMed - indexed for MEDLINE]
Free Article
17.

Immunhistochemistry by means of widely agreed-upon markers (cytokeratins 5/6 and 7, p63, thyroid transcription factor-1, and vimentin) on small biopsies of non-small cell lung cancer effectively parallels the corresponding profiling and eventual diagnoses on surgical specimens.

Pelosi G, Rossi G, Bianchi F, Maisonneuve P, Galetta D, Sonzogni A, Veronesi G, Spaggiari L, Papotti M, Barbareschi M, Graziano P, Decensi A, Cavazza A, Viale G.

J Thorac Oncol. 2011 Jun;6(6):1039-49. doi: 10.1097/JTO.0b013e318211dd16.

PMID:
21512408
[PubMed - indexed for MEDLINE]
18.

CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.

Lee HJ, Choe G, Jheon S, Sung SW, Lee CT, Chung JH.

J Thorac Oncol. 2010 May;5(5):649-57. doi: 10.1097/JTO.0b013e3181d5e554.

PMID:
20354454
[PubMed - indexed for MEDLINE]
19.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

PMID:
21623384
[PubMed - indexed for MEDLINE]
Free Article
20.

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

Mukhopadhyay S, Katzenstein AL.

Am J Surg Pathol. 2011 Jan;35(1):15-25. doi: 10.1097/PAS.0b013e3182036d05.

PMID:
21164283
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk